Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…
Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity with a third achieving 25% or more according to data presented at ADA
Higher dose of Wegovy® provided average weight loss of 21% in people…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…
Inaugural Archer Amish Award Winner Announced at IGF London 2025
U.K Minister for Culture Lisa Nandy presents $25,000 award to Dr. Shalini…
Altius Inspiro Wins 2025 Fortress Cybersecurity Award for Network Security
MANILA, Philippines, June 19, 2025 (GLOBE NEWSWIRE) -- Altius Inspiro, a leader in…
Hyundai Motor Group Announces Grand Prix Recipient and Exhibitions of the 6th VH AWARD
Hyundai Motor Group premieres five commissioned artworks of the 6th VH AWARD…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET Â | Source: Celldex Therapeutics, Inc. 77% of…
IIHM Receives National Honour for ‘Excellence in Global Hospitality Education’ from Union Education Minister Dharmendra Pradhan
NEW DELHI, June 9, 2025 /PRNewswire/ -- The International Institute of Hotel…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…